These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 16499225)
1. [Age specific reference ranges and clinical trial for complexed prostate specific antigen (cPSA)]. Haga R; Shimomura H; Ishizakaa Y; Yamakado M; Yamaguchi K; Tominaga T Rinsho Byori; 2006 Jan; 54(1):22-6. PubMed ID: 16499225 [TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen in healthy Chinese men: establishment of age-specific reference ranges. Lin WY; Gu CJ; Kao CH; Changlai SP; Wang SJ Neoplasma; 1996; 43(2):103-5. PubMed ID: 8843971 [TBL] [Abstract][Full Text] [Related]
3. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
4. Complexed PSA improves prostate cancer detection: results from a multicenter Japanese clinical trial. Okihara K; Ukimura O; Nakamura T; Ushijima S; Mizutani Y; Kawauchi A; Naya Y; Kojima M; Miki T Urology; 2006 Feb; 67(2):328-32. PubMed ID: 16461082 [TBL] [Abstract][Full Text] [Related]
5. Age-related free PSA, total PSA and free PSA/total PSA ratios: establishment of reference ranges in Chinese males. Kao CH Anticancer Res; 1997; 17(2B):1361-5. PubMed ID: 9137499 [TBL] [Abstract][Full Text] [Related]
6. Complexed prostate specific antigen: better test in the diagnosis of prostate cancer for the clinically relevant 2.5-4 ng/ml total PSA range. Mutlu N; Türkeri LN; Yencilek F; Demir A; Emerk K Can J Urol; 2009 Apr; 16(2):4558-67. PubMed ID: 19364428 [TBL] [Abstract][Full Text] [Related]
7. Age-specific reference range for serum prostate-specific antigen in Sudanese men. Abdrabo AA; Fadlalla AI; Fadl-Elmula IM Saudi Med J; 2011 Sep; 32(9):930-2. PubMed ID: 21894356 [TBL] [Abstract][Full Text] [Related]
8. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program. Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513 [TBL] [Abstract][Full Text] [Related]
9. Age-associated increase of prostate-specific antigen in a high level of men visiting urological clinics. Kobayashi T; Kinoshita H; Nishizawa K; Mitsumori K; Ogawa O; Kamoto T Int J Urol; 2005 Aug; 12(8):733-8. PubMed ID: 16174047 [TBL] [Abstract][Full Text] [Related]
10. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level. Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812 [TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. Sun L; Moul JW; Hotaling JM; Rampersaud E; Dahm P; Robertson C; Fitzsimons N; Albala D; Polascik TJ BJU Int; 2007 Apr; 99(4):753-7. PubMed ID: 17244286 [TBL] [Abstract][Full Text] [Related]
12. Blood levels of free-PSA but not complex-PSA significantly correlates to prostate release of PSA in semen in young men, while blood levels of complex-PSA, but not free-PSA increase with age. Sävblom C; Malm J; Giwercman A; Nilsson JA; Berglund G; Lilja H Prostate; 2005 Sep; 65(1):66-72. PubMed ID: 15880475 [TBL] [Abstract][Full Text] [Related]
13. Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign. Cheli CD; Levine RL; Cambetas DR; Kolker JD; Roberts SB Urology; 2002 Oct; 60(4 Suppl 1):53-9. PubMed ID: 12384164 [TBL] [Abstract][Full Text] [Related]
14. Derivatives of prostate-specific antigen as predictors of incidental prostate cancer. Froehner M; Buck LM; Koch R; Hakenberg OW; Wirth MP BJU Int; 2009 Jul; 104(1):25-8. PubMed ID: 19191782 [TBL] [Abstract][Full Text] [Related]
15. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. Moul JW; Sun L; Hotaling JM; Fitzsimons NJ; Polascik TJ; Robertson CN; Dahm P; Anscher MS; Mouraviev V; Pappas PA; Albala DM J Urol; 2007 Feb; 177(2):499-503; discussion 503-4. PubMed ID: 17222618 [TBL] [Abstract][Full Text] [Related]
16. Histological diagnosis of prostate cancer in Korean men aged 70-79 years. Shim HB; Lee SE; Park HK; Ku JH Jpn J Clin Oncol; 2007 Oct; 37(10):782-7. PubMed ID: 17913831 [TBL] [Abstract][Full Text] [Related]
17. Assessment of ethnic variation in serum levels of total, complexed and free prostate specific antigen. Comparison of Maori, Pacific Island and New Zealand European populations. Gray MA; Delahunt B; Fowles JR; Weinstein P; Cooke RR; Nacey JN Pathology; 2003 Dec; 35(6):480-3. PubMed ID: 14660097 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. Dyche DJ; Ness J; West M; Allareddy V; Konety BR J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807 [TBL] [Abstract][Full Text] [Related]
19. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer. Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142 [TBL] [Abstract][Full Text] [Related]
20. The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis. Martin NE; Chen MH; Catalona WJ; Loeb S; Roehl KA; D'Amico AV Cancer; 2008 Aug; 113(4):717-22. PubMed ID: 18615505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]